Suppr超能文献

对于 18-32 孕周、宫颈短的单胎孕妇,阴道用孕激素预防早产的效果。

The effectiveness of vaginal progesterone to prevent preterm birth in singleton pregnant women with a short cervix at 18-32 weeks gestation.

机构信息

Department of Obstetrics & Gynecology and Reproductive Medicine, Peking University First Hospital, Beijing, China.

Department of Obstetrics, Beijing Xicheng District Maternal and Child Health Care Hospital, Beijing, China.

出版信息

J Matern Fetal Neonatal Med. 2024 Dec;37(1):2412751. doi: 10.1080/14767058.2024.2412751. Epub 2024 Oct 15.

Abstract

Short cervix is a risk factor for preterm birth. Currently, both international and domestic studies about progesterone's effectiveness are limited to pregnant women at 18-24 weeks gestation. However, multiple studies indicated that cervical length was associated with preterm birth even before 32 weeks of gestation. Therefore, this study expanded the gestational week range to investigate whether progesterone can reduce the rate of preterm birth in singleton pregnant women with a short cervix at 18-32 weeks gestation. Pregnant women who underwent prenatal examination at Peking University First Hospital from January 2016 to August 2020 were prospectively followed. A total of 132 asymptomatic singleton pregnant women at 18-32 weeks gestation with a cervical length <25 mm were ultimately enrolled. According to the method of treatment, the participants were divided into progesterone group (80 patients) and control group (52 patients). The rate of preterm birth (PTB) at different stages was compared between two groups. (1) There was no significant difference in the total preterm birth rate (18.8% vs. 21.2%, RR 0.886[0.442-1.777],  = 0.734). (2) Stratified analysis found that, for pregnant women at <24 weeks gestation, there was a significant difference in the rate of PTB at <32 weeks (2.8% vs. 33.3%,  = 0.021). For women at 24-28weeks gestation, significant difference was not found in the rate of PTB at <37 weeks gestation (25% vs. 42.9%, RR = 0.583[0.186-1.831],  = 0.682), neither for women at after 28 weeks(12.5% vs. 11.1%,1.12[0.27-4.59],  = 1). (3) Vaginal progesterone was not associated with low birth weight (13.8% vs. 19.2%,  = 0.4), or preterm birth-related complications such as respiratory distress syndrome (3.8% vs. 7.7%,  = 0.555), aspiration pneumonia (22.5% vs. 19.2%,  = 0.653) and sepsis (2.5% vs. 7.7%,  = 0.331). For pregnant women with a short cervix at 18-24 weeks gestation, the rate of preterm birth before 32 weeks could be significantly reduced. For women with a short cervix at 24-28 weeks gestation, the rate of preterm birth could be reduced, while there was no significant effect for pregnant women. Further studies with a larger sample size and randomized controlled researches are needed.

摘要

宫颈短是早产的一个风险因素。目前,国内外关于孕激素有效性的研究仅限于 18-24 孕周的孕妇。然而,多项研究表明,宫颈长度与早产有关,即使在 32 孕周之前也是如此。因此,本研究将孕周范围扩大,以探讨孕激素是否能降低 18-32 孕周宫颈短的单胎孕妇的早产率。

2016 年 1 月至 2020 年 8 月,在北京大学第一医院进行产前检查的孕妇被前瞻性随访。最终纳入了 132 名 18-32 孕周、宫颈长度<25mm 的无症状单胎孕妇。根据治疗方法,将参与者分为孕激素组(80 例)和对照组(52 例)。比较两组不同阶段的早产率(PTB)。

(1)总早产率无显著差异(18.8% vs. 21.2%,RR 0.886[0.442-1.777],=0.734)。

(2)分层分析发现,对于<24 孕周的孕妇,<32 孕周的早产率有显著差异(2.8% vs. 33.3%,=0.021)。对于 24-28 孕周的孕妇,<37 孕周的早产率无显著差异(25% vs. 42.9%,RR=0.583[0.186-1.831],=0.682),对于 28 孕周后的孕妇也无显著差异(12.5% vs. 11.1%,1.12[0.27-4.59],=1)。

(3)阴道用孕激素与低出生体重(13.8% vs. 19.2%,=0.4)或早产相关并发症如呼吸窘迫综合征(3.8% vs. 7.7%,=0.555)、吸入性肺炎(22.5% vs. 19.2%,=0.653)和败血症(2.5% vs. 7.7%,=0.331)无关。

对于 18-24 孕周宫颈短的孕妇,可显著降低<32 孕周的早产率。对于 24-28 孕周宫颈短的孕妇,可降低早产率,但对孕妇无显著影响。需要进一步进行更大样本量的随机对照研究。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验